"renal cell cancer" trang 5 - tải miễn phí từ tailieunhanh
Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer

Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
7    53    1
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer
15    8    1
Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer
9    92    0
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis
13    81    0
Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma

Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma
10    78    0
Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma
12    77    1
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: A case report and literature review

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: A case report and literature review
6    76    1
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2

Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
5    38    1
ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma
7    53    1
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study
10    57    1
Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients

Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients
10    40    1
Insulin-like growth factor-1 signaling in renal cell carcinoma

Insulin-like growth factor-1 signaling in renal cell carcinoma
11    55    1
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer

Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
14    69    1
Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain

Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain
9    71    1
Older renal cell cancer patients experience increased rates of venous thromboembolic events: A retrospective cohort study of SEER-Medicare data

Older renal cell cancer patients experience increased rates of venous thromboembolic events: A retrospective cohort study of SEER-Medicare data
10    26    1
Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: An open-label phase 1b study

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: An open-label phase 1b study
9    37    1
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy data from a multi-institutional study in Japan

Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy data from a multi-institutional study in Japan
8    38    1
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma

Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma
12    36    1
A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes

A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
12    25    1
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer

Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
12    18    1